Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism

Despite great public health advances achieved by COVID-19 vaccines, rare side effects may impact the public acceptance. Guillain-Barre Syndrome has increasingly been reported with adenoviral-based vaccines. This perspective proposes a possible mechanism underlying this rare but clinically significan...

Descripción completa

Detalles Bibliográficos
Autor principal: Kadkhoda, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Letter to Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837490/
https://www.ncbi.nlm.nih.gov/pubmed/35185263
http://dx.doi.org/10.1016/j.mehy.2022.110792
_version_ 1784649920948469760
author Kadkhoda, Kamran
author_facet Kadkhoda, Kamran
author_sort Kadkhoda, Kamran
collection PubMed
description Despite great public health advances achieved by COVID-19 vaccines, rare side effects may impact the public acceptance. Guillain-Barre Syndrome has increasingly been reported with adenoviral-based vaccines. This perspective proposes a possible mechanism underlying this rare but clinically significant side effect thereby providing insights for improving our current vaccines against COVID-19.
format Online
Article
Text
id pubmed-8837490
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88374902022-02-14 Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism Kadkhoda, Kamran Med Hypotheses Letter to Editors Despite great public health advances achieved by COVID-19 vaccines, rare side effects may impact the public acceptance. Guillain-Barre Syndrome has increasingly been reported with adenoviral-based vaccines. This perspective proposes a possible mechanism underlying this rare but clinically significant side effect thereby providing insights for improving our current vaccines against COVID-19. Elsevier Ltd. 2022-03 2022-02-12 /pmc/articles/PMC8837490/ /pubmed/35185263 http://dx.doi.org/10.1016/j.mehy.2022.110792 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to Editors
Kadkhoda, Kamran
Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
title Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
title_full Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
title_fullStr Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
title_full_unstemmed Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
title_short Post-adenoviral-based vaccines Guillain-Barre Syndrome: A proposed mechanism
title_sort post-adenoviral-based vaccines guillain-barre syndrome: a proposed mechanism
topic Letter to Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837490/
https://www.ncbi.nlm.nih.gov/pubmed/35185263
http://dx.doi.org/10.1016/j.mehy.2022.110792
work_keys_str_mv AT kadkhodakamran postadenoviralbasedvaccinesguillainbarresyndromeaproposedmechanism

Ejemplares similares